|
cancer |
9 |
|
toxic epidermal necrolysis |
9 |
|
asians |
8 |
|
ocular surface disease |
8 |
|
severe cutaneous adverse reactions |
8 |
|
stevens–johnson syndrome |
8 |
|
psoriasis |
7 |
|
atherosclerosis |
6 |
|
carotid artery diseases - epidemiology - ultrasonography |
6 |
|
chinese |
6 |
|
coronary artery disease - epidemiology - radiography |
6 |
|
cross-sectional studies |
6 |
|
multidetector computed tomography |
6 |
|
psoriasis - epidemiology |
6 |
|
stevens-johnson syndrome |
6 |
|
adverse drug reaction |
5 |
|
agranulocytosis |
5 |
|
pharmacoepidemiology |
5 |
|
autoantibody |
4 |
|
female |
4 |
|
humans |
4 |
|
immunodeficiency |
4 |
|
interferon-gamma |
4 |
|
mycobacteriosis |
4 |
|
mycosis |
4 |
|
reactive dermatosis |
4 |
|
sweet's syndrome |
4 |
|
varicella zoster virus |
4 |
|
aged |
3 |
|
arterial stiffness |
3 |
|
endothelial progenitor cells |
3 |
|
fatal outcome |
3 |
|
lymphoma, extranodal nk-t-cell - complications - diagnosis |
3 |
|
paraneoplastic syndromes - etiology - pathology |
3 |
|
pathogeny |
3 |
|
pemphigus - etiology - pathology |
3 |
|
pulse wave velocity |
3 |
|
adult |
2 |
|
alopecia - etiology |
2 |
|
antiparasitic agents - administration & dosage |
2 |
|
diagnosis, differential |
2 |
|
hydralazine |
2 |
|
ivermectin - administration & dosage |
2 |
|
lupus erythematosus, systemic - complications |
2 |
|
medical sciences |
2 |
|
psoriasis - diagnosis - drug therapy - parasitology |
2 |
|
renal failure |
2 |
|
scabies - diagnosis - drug therapy - parasitology |
2 |
|
scalp dermatoses - diagnosis - drug therapy - parasitology |
2 |
|
age distribution |
1 |
|
aged, 80 and over |
1 |
|
allopurinol - adverse effects |
1 |
|
asian continental ancestry group - ethnology |
1 |
|
body mass index |
1 |
|
body sculpting |
1 |
|
breast cancer |
1 |
|
breast neoplasms - diagnosis - epidemiology |
1 |
|
case-control studies |
1 |
|
china - epidemiology |
1 |
|
comorbidity |
1 |
|
confidence intervals |
1 |
|
cutaneous t-cell lymphoma |
1 |
|
dermatology and venereology |
1 |
|
dress |
1 |
|
drug eruptions - ethnology - genetics |
1 |
|
fractional photothermolysis |
1 |
|
genetic predisposition to disease - ethnology - genetics |
1 |
|
genotype |
1 |
|
high-intensity focused ultrasound |
1 |
|
hla-b antigens - genetics |
1 |
|
hong kong - ethnology |
1 |
|
incidence |
1 |
|
lymphomatoid papulosis |
1 |
|
male |
1 |
|
middle aged |
1 |
|
non-invasive |
1 |
|
nonablative |
1 |
|
obesity |
1 |
|
obesity - diagnosis - epidemiology |
1 |
|
odds ratio |
1 |
|
palliative care |
1 |
|
paraneoplastic syndromes - pathology |
1 |
|
pharmacogenetics |
1 |
|
photoaging |
1 |
|
postmenopause |
1 |
|
premenopause |
1 |
|
primary cutaneous cd30+ lymphoproliferative disorder |
1 |
|
probability |
1 |
|
reference values |
1 |
|
risk assessment |
1 |
|
scars |
1 |
|
scleromyxedema - pathology |
1 |
|
survival rate |
1 |
|
thymoma - drug therapy - pathology |
1 |
|
thymus neoplasms - drug therapy - pathology |
1 |
|
treatment |
1 |
|
uricosuric agents - therapeutic use |
1 |
